This project has received funding from the European Union’s Horizon 2020 Research and Innovation Programme under the Marie Sklodowska-Curie grant agreement Nº 847635.
Bio-Sourcing’s unique technological platform enables affordable production of complex protein for animal or human health. The company currently focuses on animal health and aims to harness nature’s power to produce large quantities of specific proteins in milk in order to increase the availability of drugs. Bio-Sourcing’s groundbreaking technology is applicable to a wide range of veterinary applications. Biological drugs such as antibodies, anti-infectious, anti-inflammatory drugs and vaccines can improve, decrease mortality and disease, reduce antibiotic usage, increase efficient vaccine access, improve weaning and decrease carbon footprint. Bio-Sourcing is partnering with major animal health companies around the globe who share its vision – to convert human therapeutic solutions into affordable animal biological drugs and thanks to healthier animals, contributing to sustainable development and to the WHO concept of “One World, One Health”.
2 sites : labs for molecular biology and embryology and farm for veterinary.